Six Dental Hygienists You Want to Know
In the 12th edition of this annual feature, Dimensions of Dental Hygiene recognizes the best and the brightest in academia, clinical practice, industry, “mover and shaker,” public health, and research.
Author
New Reference Values for Developing Dentition
Children’s teeth don’t develop along the traditionally accepted timeline, according to a study from the University of Missouri School of Medicine.
National Campaign Launched to Reduce Opioid Misuse
The Medicaid|MedicarelCHIP Services Dental Association, a nonprofit organization that advocates for quality oral health care for Medicaid, Medicare and Children’s Health Insurance Program beneficiaries, has launched a campaign aimed at…
Insurance Company and Dental Industry Team up to Reduce Pneumonia Risk in Surgery Patients
Nonventilator health care-associated pneumonia (NV-HAP)—when patients receive treatment in a health-care setting and develop pneumonia unrelated to their treatment and without the presence of a ventilator—is a significant issue that…
Dimensions’ Corporate Council Welcomes a New but Familiar Member
Lynn Pencek, RDH, MS, was a longtime member of Dimensions of Dental Hygiene’s Corporate Council when she was working with Orascoptic as a senior district manager.
December 2019 Top Brand Ambassadors
Each month, Newsline features some of our most active Dimensions of Dental Hygiene Brand Ambassadors.
American Dental Association Announces Interim Policy on Vaping
The American Dental Association (ADA) has announced a new interim policy on vaping, calling for a total ban on vaping products that aren’t approved by the Food and Drug Administration (FDA) for tobacco cessation purposes.
Caring for Patients With Heart Disease
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States, claiming about 2,200 deaths daily or one death every 40 seconds. Globally, CVDs accounted for more than 17 million deaths, representing over…
Statement by the DentaQuest Partnership for Oral Health Advancement on Passage of The Lower Drug…
A statement from Myechia Minter-Jordan, MD, MBA, DentaQuest chief impact officer.
